Cabot Corporation (NYSE:CBT) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Cabot Corporation (NYSE:CBTGet Free Report) have been given an average rating of “Hold” by the seven ratings firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and two have issued a buy rating on the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is $85.80.

CBT has been the subject of several analyst reports. UBS Group upped their price objective on Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a research note on Friday, May 8th. JPMorgan Chase & Co. lifted their target price on Cabot from $68.00 to $70.00 and gave the company an “underweight” rating in a research note on Wednesday, May 13th. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a report on Sunday, June 14th. Weiss Ratings restated a “hold (c)” rating on shares of Cabot in a research note on Tuesday, May 26th. Finally, Truist Financial started coverage on Cabot in a report on Monday, June 8th. They set a “buy” rating and a $98.00 price target for the company.

Check Out Our Latest Research Report on Cabot

Institutional Trading of Cabot

Several hedge funds have recently made changes to their positions in the company. Torren Management LLC purchased a new position in Cabot during the fourth quarter worth $26,000. Rothschild Investment LLC lifted its position in shares of Cabot by 170.4% in the fourth quarter. Rothschild Investment LLC now owns 411 shares of the specialty chemicals company’s stock valued at $27,000 after acquiring an additional 259 shares in the last quarter. Geneos Wealth Management Inc. boosted its stake in shares of Cabot by 409.0% during the first quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock valued at $38,000 after acquiring an additional 364 shares during the last quarter. Global Retirement Partners LLC boosted its stake in shares of Cabot by 1,606.9% during the fourth quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after acquiring an additional 466 shares during the last quarter. Finally, Danske Bank A S purchased a new stake in Cabot during the 3rd quarter worth about $38,000. Institutional investors and hedge funds own 93.18% of the company’s stock.

Cabot Trading Up 1.2%

NYSE CBT opened at $90.15 on Friday. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.96 and a current ratio of 1.45. The firm has a market cap of $4.65 billion, a PE ratio of 17.04, a P/E/G ratio of 11.73 and a beta of 0.83. Cabot has a one year low of $58.33 and a one year high of $94.53. The firm’s fifty day moving average is $86.94 and its two-hundred day moving average is $78.73.

Cabot (NYSE:CBTGet Free Report) last announced its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, beating analysts’ consensus estimates of $1.47 by $0.14. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The business had revenue of $904.00 million during the quarter, compared to analysts’ expectations of $900.30 million. During the same period in the prior year, the company earned $1.90 earnings per share. The business’s revenue was down 3.4% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. Analysts expect that Cabot will post 6.35 earnings per share for the current year.

Cabot Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be given a dividend of $0.4725 per share. The ex-dividend date is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a yield of 2.1%. Cabot’s dividend payout ratio is presently 35.73%.

Cabot Company Profile

(Get Free Report)

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.

Featured Stories

Analyst Recommendations for Cabot (NYSE:CBT)

Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.